Spinal cord injury (SCI), a serious neurological disease, has few therapeutic interventions. A small molecule, P7C3, has been confirmed to play a role in neuroprotection of some neurological diseases. But the effect of P7C3 on acute SCI has not been investigated. Here, we observed the therapeutic effect of P7C3 for alleviating the neurological damage by direct subcutaneous injection after SCI once daily for 7 or 14 days in a rat model. The locomotion and histopathological changes were evaluated. Our results demonstrated that P7C3 treatment contributed to functional recovery and tissue repair following SCI. Improved locomotor function with P7C3 treatment was correlated with increased survival of neurons and oligodendrocytes (OLs) and proliferation of OLs and their progenitors, which resulted in tissue repair and myelination in the injured SC. P7C3 treatment also restored the nicotinamide adenine dinucleotide level in the SC, which was reduced by SCI. These results suggest that P7C3 plays a role in improving neurological outcome following SCI.
Impact statement
Spinal cord injury (SCI), a serious neurological disease, has few therapeutic interventions. This study confirms for the first time that P7C3 is conducive to functional recovery and tissue repair after SCI. P7C3 treatment can rescue the nicotinamide adenine dinucleotide level of the injured spinal cord, which results in more survival of neurons and oligodendrocytes (OLs) and proliferation of OLs and their progenitors, and thus increase myelination and tissue repair. This result indicates that P7C3 plays a role in improving neurological outcome following SCI.
QuencerRMBungeRP.The injured spinal cord: imaging, histopathologic clinical correlates, and basic science approaches to enhancing neural function after spinal cord injury. Spine1996;
21:2064–6
3.
BeattieMS.Inflammation and apoptosis: linked therapeutic targets in spinal cord injury. Trends Mol Med2004;
10:580–3
4.
FatimaGSharmaVPDasSKMahdiAA.Oxidative stress and antioxidative parameters in patients with spinal cord injury: implications in the pathogenesis of disease. Spinal Cord2015;
53:3–6
5.
LamTChenZSayed-AhmedMMKrassioukovAAl-YahyaAA.Potential role of oxidative stress on the prescription of rehabilitation interventions in spinal cord injury. Spinal Cord2013;
51:656–62
6.
LiuDChenJJiangTLiWHuangYLuXLiuZZhangWZhouZDingQSantosHAYinGFanJ.Biodegradable spheres protect traumatically injured spinal cord by alleviating the glutamate-induced excitotoxicity. Adv Mater2018;
30:e1706032
7.
LiuDXuGYPanEMcAdooDJ.Neurotoxicity of glutamate at the concentration released upon spinal cord injury. Neuroscience1999;
93:1383–9
8.
PapastefanakiFMatsasR.From demyelination to remyelination: the road toward therapies for spinal cord injury. Glia2015;
63:1101–25
9.
ChenHJiHZhangMLiuZLaoLDengCChenJZhongG.An agonist of the protective factor SIRT1 improves functional recovery and promotes neuronal survival by attenuating inflammation after spinal cord injury. J Neurosci2017;
37:2916–30
10.
PieperAAMcKnightSLReadyJM.P7C3 and an unbiased approach to drug discovery for neurodegenerative diseases. Chem Soc Rev2014;
43:6716–26
11.
PieperAAXieSCapotaEEstillSJZhongJLongJMBeckerGLHuntingtonPGoldmanSEShenCHCapotaMBrittJKKottiTUreKBratDJWilliamsNSMacMillanKSNaidooJMelitoLHsiehJDe BrabanderJReadyJMMcKnightSL.Discovery of a proneurogenic, neuroprotective chemical. Cell2010;
142:39–51
12.
WangGHanTNijhawanDTheodoropoulosPNaidooJYadavalliSMirzaeiHPieperAAReadyJMMcKnightSL.P7C3 neuroprotective chemicals function by activating the rate-limiting enzyme in NAD salvage. Cell2014;
158:1324–34
13.
De Jesus-CortesHMillerADBrittJKDeMarcoAJDe Jesus-CortesMStuebingENaidooJVazquez-RosaEMorlockLWilliamsNSReadyJMNarayananNSPieperAA.Protective efficacy of P7C3-S243 in the 6-hydroxydopamine model of Parkinson’s disease. NPJ Parkinson’s Dis2015;
1:15010
14.
De Jesus-CortesHXuPDrawbridgeJEstillSJHuntingtonPTranSBrittJTeslaRMorlockLNaidooJMelitoLMWangGWilliamsNSReadyJMMcKnightSLPieperAA.Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson disease. Proc Natl Acad Sci U S A2012;
109:17010–15
15.
NaidooJDe Jesus-CortesHHuntingtonPEstillSMorlockLKStarwaltRManganoTJWilliamsNSPieperAAReadyJM.Discovery of a neuroprotective chemical, (S)-N-(3-(3,6-dibromo-9H-carbazol-9-yl)-2-fluoropropyl)-6-methoxypyridin-2-amine [(-)-P7C3-S243], with improved druglike properties. J Med Chem2014;
57:3746–54
16.
BlayaMOBramlettHMNaidooJPieperAADietrichWD.Neuroprotective efficacy of a proneurogenic compound after traumatic brain injury. J Neurotrauma2014;
31:476–86
17.
DutcaLMStasheffSFHedberg-BuenzARuddDSBatraNBlodiFRYorekMSYinTShankarMHerleinJANaidooJMorlockLWilliamsNKardonRHAndersonMGPieperAAHarperMM.Early detection of subclinical visual damage after blast-mediated TBI enables prevention of chronic visual deficit by treatment with P7C3-S243. Invest Ophthalmol Vis Sci2014;
55:8330–41
18.
YinTCBrittJKDe Jesus-CortesHLuYGenovaRMKhanMZVoorheesJRShaoJKatzmanACHuntingtonPJWassinkCMcDanielLNewellEADutcaLMNaidooJCuiHBassukAGHarperMMMcKnightSLReadyJMPieperAA.P7C3 neuroprotective chemicals block axonal degeneration and preserve function after traumatic brain injury. Cell Rep2014;
8:1731–40
19.
KempSWSzynkarukMStanoulisKNWoodMDLiuEHWillandMPMorlockLNaidooJWilliamsNSReadyJMManganoTJBeggsSSalterMWGordonTPieperAABorschelGH.Pharmacologic rescue of motor and sensory function by the neuroprotective compound P7C3 following neonatal nerve injury. Neuroscience2015;
284:202–16
20.
TeslaRWolfHPXuPDrawbridgeJEstillSJHuntingtonPMcDanielLKnobbeWBurketATranSStarwaltRMorlockLNaidooJWilliamsNSReadyJMMcKnightSLPieperAA.Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A2012;
109:17016–21
21.
WalkerAKRiveraPDWangQChuangJCTranSOsborne-LawrenceSEstillSJStarwaltRHuntingtonPMorlockLNaidooJWilliamsNSReadyJMEischAJPieperAAZigmanJM.The P7C3 class of neuroprotective compounds exerts antidepressant efficacy in mice by increasing hippocampal neurogenesis. Mol Psychiatry2015;
20:500–8
22.
GrunerJA.A monitored contusion model of spinal cord injury in the rat. J Neurotrauma1992;
9:123–6; discussion 26–8
23.
YaoZFWangYLinYHWuYZhuAYWangRShenLXiJQiQJiangZQLuHZHuJG.Transplantation of PDGF-AA-Overexpressing oligodendrocyte precursor cells promotes recovery in rat following spinal cord injury. Front Cell Neurosci2017;
11:79
24.
BassoDMBeattieMSBresnahanJC.A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma1995;
12:1–21
25.
GuoXYDuanFXChenJWangYWangRShenLQiQJiangZQZhuAYXiJLuHZHuJG.Subcutaneous administration of PDGF-AA improves the functional recovery after spinal cord injury. Front Neurosci2019;
13:6
26.
BassoDMFisherLCAndersonAJJakemanLBMcTigueDMPopovichPG.Basso mouse scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma2006;
23:635–59
27.
Morris-BlancoKCCohanCHNeumannJTSickTJPerez-PinzonMA.Protein kinase C epsilon regulates mitochondrial pools of Nampt and NAD following resveratrol and ischemic preconditioning in the rat cortex. J Cereb Blood Flow Metab2014;
34:1024–32
28.
KhayrullinaGBermudezSByrnesKR.Inhibition of NOX2 reduces locomotor impairment, inflammation, and oxidative stress after spinal cord injury. J Neuroinflammation2015;
12:172
29.
KeirsteadHSNistorGBernalGTotoiuMCloutierFSharpKStewardO.Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci2005;
25:4694–705
30.
XuXMOniferSM.Transplantation-mediated strategies to promote axonal regeneration following spinal cord injury. Respir Physiol Neurobiol2009;
169:171–82
31.
BeattieMSHermannGERogersRCBresnahanJC.Cell death in models of spinal cord injury. Prog Brain Res2002;
137:37–47
32.
StenuddMSabelstromHFrisenJ.Role of endogenous neural stem cells in spinal cord injury and repair. JAMA Neurol2015;
72:235–7
33.
TranAPWarrenPMSilverJ.The biology of regeneration failure and success after spinal cord injury. Physiologic Rev2018;
98:881–917
34.
YingW.NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid Redox Signal2008;
10:179–206
35.
WangPMiaoCY.NAMPT as a therapeutic target against stroke. Trends Pharmacologic Sci2015;
36:891–905
36.
SteinLRImaiS.Specific ablation of Nampt in adult neural stem cells recapitulates their functional defects during aging. EMBO J2014;
33:1321–40
37.
LorisZBPieperAADietrichWD.The neuroprotective compound P7C3-A20 promotes neurogenesis and improves cognitive function after ischemic stroke. Exp Neurol2017;
290:63–73
38.
WangSNXuTYLiWLMiaoCY.Targeting nicotinamide phosphoribosyltransferase as a potential therapeutic strategy to restore adult neurogenesis. CNS Neurosci Ther2016;
22:431–9
39.
GenselJCZhangB.Macrophage activation and its role in repair and pathology after spinal cord injury. Brain Res2015;
1619:1–11
40.
PlemelJRKeoughMBDuncanGJSparlingJSYongVWStysPKTetzlaffW.Remyelination after spinal cord injury: is it a target for repair?Prog Neurobiol2014;
117:54–72
41.
KronerARosas AlmanzaJ.Role of microglia in spinal cord injury. Neurosci Lett2019;
709:134370
